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ABSTRACT
INTRODUCTION: Breathwork, or the specific act of controlling breathing to
elicit a desired outcome, is not only a potential way to improve one’s mental well-being
but also to alter adaptative responses through gas exchange at the capillary level.
Increasing tolerance to carbon dioxide (CO2) has been positively correlated with
improvement in athletic performance and reduction of stress and anxiety. However, there
does not exist a validated non-invasive test to accurately measure one’s tolerance to CO2.
PURPOSE: The purpose of this study was to validate the only currently known CO2
tolerance (CO2T) field test against measured maximal dissolved CO2 and maximal
ventilatory carbon dioxide (𝑉𝑉̇ CO2max) in endurance athletes. HYPOTHESIS: It was

hypothesized that the novel CO2T field test would have a strong positive correlation to

clinical CO2 measurements, there would be no observable differences in comparative
values between the CO2T field test and clinical CO2 measurements between sexes, and
there would be a negative correlation between anaerobic capacity and CO2T.
METHODS: Twenty-eight (n=28, 19 males, 9 females) participants reported to the
Human Performance Laboratory on two separate occasions, separated by 48 hours, for
testing. Peak CO2 levels were generated via repeated 30-second Wingate anaerobic
power intervals with two minutes of rest in-between. Participants continued the Wingate
tests until a plateau of peak power was achieved or volitional fatigue. CO2 data were
recorded at the end of each interval. Day one consisted of a study orientation, informed
v

consent, anthropometric measurements, CO2T field test, and ventilatory CO2
measurements during the repeated Wingate tests. Day two consisted of a second CO2T
field test, end-tidal CO2 (EtCO2), and lactate (BL) measurements during the repeated
Wingate tests. STATISTICS: Repeated measures ANOVA and paired t-test were used
to determine if differences existed between CO2T times, EtCO2, anaerobic capacity (AC),
and blood BL values. Pearson correlation coefficient analysis was used to determine if
there was a relationship between CO2T times and all primary research variables.
RESULTS: The CO2T field test showed to have a very high degree of intra-rater
reliability but did not show any validity to CO2 measurements. Statistical analysis
showed a high positive correlation between CO2T tests one and two (r = 0.989, p < 0.01)
and no significant difference so an average score was used for analysis. A moderate
positive correlation to HRpeak for CO2Tavg (r = 0.38, p < 0.05), and an indirect
correlation to EtCO2(1) (r = -0.342, p < 0.05). Correlations between CO2T tests and all
other variables did not reach statistical significance. CONCLUSION: While reliable,
the novel CO2T field test does not seem to be a valid measurement of physiological
levels of CO2. The test was shown to have a high degree of intra-rater reliability and
could be used to show trends over time but does not give an accurate portrayal of actual
CO2 production, accumulation, and tolerance.

vi

TABLE OF CONTENTS
ACKNOWLEDGMENTS ..............................................................................................iv
ABSTRACT .................................................................................................................... 5
LIST OF TABLES .......................................................................................................... x
LIST OF FIGURES ........................................................................................................xi
LIST OF ABBREVIATIONS ........................................................................................xii
CHAPTER ONE: INTRODUCTION .............................................................................. 1
Production, Transportation, and Elimination of Carbon Dioxide........................... 1
Measurement of Carbon Dioxide.......................................................................... 2
Need of the Study................................................................................................. 4
Purpose .................................................................................................... 4
Hypothesis................................................................................................ 5
Operational Definitions ........................................................................................ 5
Endurance Athletes................................................................................... 5
Dissolved CO2 .......................................................................................... 5
Maximal CO2 ........................................................................................... 5
CO2 Tolerance .......................................................................................... 6
Limitations/Delimitations ..................................................................................... 6
Study Significance ............................................................................................... 6
CHAPTER TWO: REVIEW OF LITTERATURE ........................................................... 7

vii

Introduction ......................................................................................................... 7
CO2 Chemosensitivity ....................................................................................... 10
Psychological Effects of CO2 ............................................................................. 12
Manipulation of Tolerance to CO2 ..................................................................... 13
Measurement of CO2 ......................................................................................... 15
CO2 and Physical Activity ................................................................................. 21
Validation of Field Tests.................................................................................... 22
Conclusion ........................................................................................................ 25
CHAPTER THREE METHODS ................................................................................... 26
Participants ........................................................................................................ 26
Measurements ................................................................................................... 26
Anthropometrics and Medical History .................................................... 26
Anaerobic Graded Exercise Test: ........................................................... 27
Blood Lactate ......................................................................................... 28
Maximal Heart Rate ............................................................................... 28
CO2 Measurement ............................................................................................. 28
End-Tidal CO2 (EtCO2).......................................................................... 28
Maximal Expired CO2 (𝑉𝑉𝑉𝑉O2 max) ........................................................ 28
CO2T Field Test ..................................................................................... 29
Procedure .......................................................................................................... 29
Day 1: Orientation/Informed Consent/anthropometric measurements/CO2T
Field Test/ Ventilatory CO2 .................................................................... 29
Day 2 – 48 hrs of rest from day 1: CO2T Field Test/EtCO2 /BL
Measurements ........................................................................................ 30

viii

Data Analysis ..................................................................................................... 31
CHAPTER FOUR: VALIDATION OF NON-INVASIVE CO2 TOLERANCE FIELD
TEST ............................................................................................................................. 32
Introduction ....................................................................................................... 32
Methods ............................................................................................................. 33
Participants ............................................................................................. 33
Anaerobic Threshold Test ....................................................................... 34
Procedures ......................................................................................................... 34
Day 1 Testing ......................................................................................... 35
Day 2 Testing ......................................................................................... 36
Data Analysis ......................................................................................... 37
Results ............................................................................................................... 37
CO2 Tolerance ........................................................................................ 39
Primary Research Variables .................................................................... 40
Discussion.......................................................................................................... 41
REFERENCES .............................................................................................................. 47
APPENDIX A ............................................................................................................... 57
APPENDIX B ............................................................................................................... 61
APPENDIX C ............................................................................................................... 63
APPENDIX D ............................................................................................................... 65
APPENDIX E................................................................................................................ 70
APPENDIX F ................................................................................................................ 83

ix

LIST OF TABLES
Table 1

Anaerobic Threshold Test68 .................................................................... 34

Table 2

Study Participant Characteristic ............................................................. 37

Table 3

Mean ± SD for all Research Variables Between Sex............................... 38

Table 4

Correlations between CO2Tavg and all Research Variables .................... 41

x

LIST OF FIGURES
Figure 1

Study Outline of Visits and Variables Measured .....................................36

Figure 2

CO2T Distribution by Sex .......................................................................39

Figure 3 and Figure 4 Changes in BL and EtCO2 across intervals ...............................41
Figure 5

CO2T and EtCO2 Comparison.................................................................59

xi

LIST OF ABBREVIATIONS
CO2

Carbon Dioxide

HRpeak

Peak Heart Rate

V ̇O2max

Maximum Oxygen Consumption

EtCO2

End Tidal Carbon Dioxide

HR

Heart Rate

VE

Ventilation

CO2T

Carbon Dioxide Tolerance

V ̇CO2max

Maximal Carbon Dioxide Exhalation

O2

Oxygen

VBG

Venous Blood Gas

ABG

Arterial Blood Gas

BL

Blood Lactate

AC

Anaerobic Capacity

BLrel

Relative Blood Lactate

BLabs

Absolute Blood Lactate

EtCO2rel

Relative End-tidal Carbon Dioxide

EtCO2abs

Absolute End-tidal Carbon Dioxide

CO2Tavg

Average Carbon Dioxide Tolerance

xii

1

CHAPTER ONE: INTRODUCTION
Production, Transportation, and Elimination of Carbon Dioxide
Cellular respiration consists of a cascade of metabolic processes in which cells
use and convert glycogen, a stored form of the simple sugar glucose, into energy in the
form of adenosine triphosphate (ATP). These processes may or may not require oxygen
(O2) and results in the use of ATP and generation of metabolic byproducts that must be
expelled. Carbon dioxide (CO2) is one of the major byproducts of cellular respiration.
Carbon dioxide is transported in the blood by being dissolved in solution (reflected by the
partial pressure of CO2), as carbonic acid, in the form of bicarbonate, or bound to
hemoglobin.1 As energy output increases, the demand for ATP, glycogen, and oxygen
increases. As more energy is used, more CO2 is produced that must be offloaded.
Responses to the increased physiological need for O2 and increased production of CO2
are met, in part, by increasing heart rate and ventilatory rate.1 The increase in ventilation
serves dual purposes of taking in more O2 and offloading more CO2.
Under normal atmospheric conditions, O2 availability is not an issue in healthy
adults. Thus, the main reason for increased ventilation is to offload the rising levels of
CO2 as elevated CO2 levels increase perceptions of fatigue, exhaustion, and air starvation
resulting in increased anxiety and decreased performance2–4; increasing ventilation, the
metabolic cost of breathing, and the metabolic cost of physical activity2. Being able to
tolerate higher levels of CO2 will then, in turn, reduce the need for increased ventilation
rates as exercise intensity increases resulting in improved efficiency.5–7 This adaptation
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can also be beneficial during extended breath-hold freediving as rising levels of CO2
during the breath hold triggers an associated chemoreflex requiring cessation of the
breath-hold and initiation of ventilation.8,85
Measurement of Carbon Dioxide
Much like training to increase lactate threshold in power and strength athletes, as
well as aerobic training to increase maximal oxygen consumption (𝑉𝑉̇ O2max) in

endurance athletes, training to increase CO2T is gaining popularity in the freediving
community.7,9 Previous research has shown improving CO2T to be beneficial for
lowering blood acidosis, reducing oxidative stress, and improving state anxiety.3,10–12
However, although studies have shown that CO2T can be improved, there is no 'gold
standard' test to assess an individual's actual CO2T.
Carbon dioxide levels are measured in a variety of ways. The most common
laboratory test for measuring dissolved CO2 levels in blood (partial pressure (PCO2))
evaluates the change in pH in venous or arterial blood, commonly known as venous
blood gas (VBG) or arterial blood gas (ABG) analysis. As opposed to blood PCO2,
capnography is the measurement of exhaled gas PCO2 and is conducted with a
capnometer or standard metabolic cart.13 Both of these testing methods have a high level
of validity and reliability 14,15,16; however, they are expensive, require a trained
professional to administer the test, require specialized equipment, and are only found in
laboratory or medical facilities.
Almost all 'gold standard' exercise tests traditionally occur in a controlled lab
setting via expensive equipment and a trained professional. These tests include but are
not limited to, testing 𝑉𝑉̇ O2max, anaerobic capacity (AC), and body composition. To
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make testing more manageable, affordable, and easier, all of these 'gold standard' tests
have an equivalent validated field test possessing a high degree of reliability.17–19 The
need to validate simple field tests is paramount to training when access to a laboratory
and/or equipment is not available, trained technicians are not present, or there is no
surplus of money.
The only known field test used to evaluate an individual's tolerance level to CO2
is a rudimentary never validated, single-breath exhale for time25. Done over two trials
separated by two minutes of rest, individuals inhale to vital capacity and then
immediately exhale in a slow and controlled manner for as long as possible. It is
theorized that this method not only assesses pulmonary function but also one’s ability to
tolerate higher levels of CO2 in that during extended exhalation, CO2 will continue to
accumulate in the body until a maximal tolerable concentration has been reached and
normal ventilation must commence. This method was developed using the concepts of
breath-holding creating higher levels of CO2 in the body and the ability to control
exhalation uniformly results in a high level of diaphragmatic or pulmonary control.
Previous research has demonstrated this method to have a high degree of internal
reliability as well a high degree of intrarater reliability and has been used to examine the
role CO2 plays in stress and anxiety and the relationship between increasing CO2T and
submaximal physical performance.4,12 Though this test has been shown to have internal
reliability12 as well as theoretical reliability, one main limitation of these studies was that
it appears that this simple field test has never been validated against well-accepted CO2
clinical measurements.20
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Need of the Study
As freediving has gained popularity over the years, researchers have begun to
study how breath-hold divers can resist fundamental physiological urges to breathe. This
resistance is, in part, due to apnea training protocols that increase tolerance to CO2
accumulation.21 Given that CO2T is also a performance-limiting factor during exercise,
previous studies have shown that increasing tolerance to CO2 can improve sub-maximal
performance and reduce perceptions of fatigue.12 In addition, it can reduce fear and state
anxiety, as higher levels of CO2 have been shown to be associated with the triggering of
these adverse psychological responses.3,12 An increase in fear and anxiety, especially
during exercise, can then lead to poor performance outcomes or even increased injury
potential-4,12. The only current field test that exists for measurement of CO2T in humans
involves a timed maximal breath exhale, however there is minimal research into the
validity and reliability of this test. Validation of the current CO2T field test against
standardized laboratory measurements of maximal ventilatory CO2 could significantly
impact implementation of CO2T training protocols given the minimal required equipment
and the relative ease of conducting the test.22
Purpose
The purpose of this study is to validate the only known current CO2T field test
against EtCO2, maximal ventilatory carbon dioxide (𝑉𝑉̇ CO2max), BL production, and AC in

endurance athletes.
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Hypothesis
This study has three related hypotheses (H):
H1: The CO2T Field test will have a strong positive correlation to clinical CO2
measurements.
H2: Differences in comparative values between the CO2T field test and clinical CO2
measurements will not be observed between sexes.
H3: There will be a negative correlation between AC and CO2T.
Operational Definitions
Endurance Athletes
As defined for this study, "Endurance Athletes" participate in non-team sports
where key muscle groups are worked sub-maximally for prolonged periods of time.
These sports include but are not limited to road cycling, mountain biking, cyclocross,
gravel cycling, cycle touring, any running event at or longer than 5km, cross country
skiing, swimming, and race walking.23
Dissolved CO2
Dissolved CO2 is the amount of CO2 present in arterial and venous blood. Carbon
dioxide is transported back to the lungs primarily as bicarbonate as well as buffered by
water as carbonic acid, bound to hemoglobin, or directly dissolved in the blood.24
Maximal CO2
Maximal CO2 output is a measurement of the maximal volume of expired CO2
during exercise. Typically expressed as 𝑉𝑉̇ 𝐶𝐶O2 and measured as either absolute; milliliters

per minute (ml/min) or relative; ml/kg/min. Measurements are collected from expired

gases during a graded exercise test (GXT). Gases are collected in the mixing chamber of
a standard metabolic cart and then analyzed against supplied room air concentrations at
standard temperature and pressure.14
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CO2 Tolerance
CO2T can be viewed as either simple; the length of time an individual can hold
their breath, or complex, the ability to endure progressively rising levels of CO2 without
resulting in unwanted psycho-metabolic reactivity.25,26
Limitations/Delimitations
The current study population includes endurance athletes, excluding the general
population and anaerobic athletes; previous studies have shown that increasing tolerance
to CO2 has had little to no effect on performance in anaerobic athletes, thusly excluding
these and the general populations can be considered a delimitation. The study
population's age range of over 18 years and under 65 years, is considered a limitation due
to physiological changes that occur as adults age.
Study Significance
This study's completion will validate or invalidate the only known CO2T field test
currently being used, a timed controlled single breath exhale. Given the relative ease and
non-invasive nature of the current CO2T-test, validating the results will allow the field
test to be accurately applied to further research, various clinical applications, and as an
assessment tool for training CO2T.
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CHAPTER TWO: REVIEW OF LITTERATURE
Introduction
Exercise testing has long been used to measure various functional capacities and
intensity tolerance levels, diagnose cardiopulmonary diseases, identify responses to
disease interventions, and for exercise/performance testing and prescription. There are
many widely accepted clinical laboratory exercise tests, as well as validated field
tests.17,18,27 However, when measuring or calculating physiological variables, such as
𝑉𝑉̇ O2max, there exist potential drawbacks when comparing gold standard laboratory tests

to field tests. Field tests inherently do not provide as valid and reliable values; however,
they are easier to administer, cost-effective, and generally do not require special
equipment or training.17,27 As 𝑉𝑉̇ O2max is the quintessential measurement of

cardiovascular fitness, many previous studies have sought to bridge the gap between
clinical tests and field tests through the comparative analysis of results. This has led to
many 𝑉𝑉̇ O2max field tests being validated against the accepted gold standard, opening

doors for more testing opportunities. However, maximal oxygen uptake is not the only
crucial cardiorespiratory variable that can limit performance. This review will examine
the impact of CO2T on human physiology, examine the various ways CO2 is measured,
and explain the importance and need for a standardized, non-invasive, valid, and reliable
CO2T field test.
Recent studies have shown that increasing tolerance to CO2 can have sub-maximal
performance benefits for endurance athletes12, and studies have long shown that
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increasing tolerance to CO2 is critical for breath-hold divers.21,22 However, outside of
clinical laboratory tests, there does not appear to exist a validated method for measuring
CO2T. Using the rationale that with a constant increase in the duration of exhalation,
CO2 will continue to accumulate in the body until a maximal tolerable concentration has
been reached and normal ventilation must commence. In theory, a timed single breath
exhale could measure CO2T.2–4 Though using a timed breath-exhale is a cost-effective
and straightforward method compared with standard clinical tests, it has neither been
validated nor implemented enough in a controlled setting to be considered truly reliable
or valid. The purpose of this study is to validate the only currently known CO2T field test
against measured exhaled 𝑉𝑉̇ 𝐶𝐶O2max in endurance athletes.

Many factors control the breathing or ventilation rate. The primary ventilatory

drive is hydrogen ions (H+) and secondarily bicarbonate levels (HCO3-) and arterial CO2
levels. An increase in cellular respiration metabolites leads to an overall decrease in
blood pH (blood tends to be slightly basic at a pH of 7.35 – 7.45).28 An acute increase in
respiratory metabolites will trigger both peripheral and central chemoreceptors located in
the carotid bodies and the medulla oblongata, respectively. The relationship between
rising cellular respiration products and ventilatory response is highlighted in a review by
Dr. James Duffin. In this review, Dr. Duffin showed a progressive linear increase in
ventilation as PCO2 rose.28 This correlation is significant in understanding how
ventilation increases in response to exercise.
Elevated levels of CO2 in the bloodstream, otherwise known as hypercapnia, are
typically caused by poor or inadequate ventilation. Hypercapnia can be self-induced, as
seen in competitive breath-hold divers and during exercise or result from pulmonary

9
conditions such as interstitial lung disease or chronic obstructive pulmonary disease.
Being hypercapnic is undesirable as many physiological and psychological problems can
occur. In severe cases, referred to as acute hypercapnic respiratory failure, it can be a
medical emergency brought on by conditions associated with diminished neuromuscular
transmission, defects of the ribcage, or as a sudden result of chronic hypercapnia.29
Chronic hypercapnia is typically not seen in healthy individuals as some form of
impairment within the pulmonary system that limits alveolar ventilation and reduces CO2
offloading, in turn causing blood concentrations to rise, needs to exist.30 Chronic
hypercapnia results in a consistent lack of energy, wheezing, dyspnea, and frequent
respiratory infections. This condition also makes it very difficult to exercise, as even
minor increased energy expenditure will exacerbate the condition.31
The general population and athletes alike can also experience adverse symptoms
of acute hypercapnia such as dyspnea (breathlessness), anxiety, and diminished
performance in sports and activities4,12,21,26,31. An increase in CO2 concentration in the
blood will lead to respiratory acidosis. Normally, the body will regulate through
metabolic compensation, wherein a sudden increase of H+ secretion from the kidneys
occurs. Higher concentrations of H+ ions increase ventilatory drive with the end goal of
off-loading excess CO2 to rebalance blood pH. A sudden shift, or increase, in ventilatory
drive, results in increased breathing depth and frequency. In athletes, a decrease in
energy expenditure is necessary to decrease the amount of CO2 that is being produced
from cellular respiration as respiratory rate and depth will plateau.28,32 These shifts in
ventilatory drive, cardiac output, and CO2 directly correlate with an individual's
ventilatory threshold. Ventilatory threshold is the point at which ventilation
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exponentially increases in relation to O2 consumption. This threshold reflects BL levels
(lactate threshold) and anaerobiosis. The amount of time an individual can withstand this
shift in ventilatory drive can be seen as their ability to tolerate ever-rising levels of CO2
in their system, and thus as a measure of CO2T.4,12,25
CO2 Chemosensitivity
Chemoresponsiveness is influenced by age, sex, genetics, and apnea conditions.
A recent review by Chowdhuri and Badr (2017) showed the importance of
cerebrovascular responsiveness in ventilation. Decreases in cerebral blood flow allow an
accumulation of CO2, which then stimulates the medulla and increases ventilation rates.
This decrease in cerebral blood flow can be attributed to specific gene mutations, leading
researchers to believe that one cause of sleep apnea and sudden infant death syndrome
can be traced back to these genetic mutations. Apnea conditions, mainly central sleep
apnea, increases blood CO2 and is more commonly found in men with low testosterone.
As humans age, they experience a decrease in cerebrovascular responsiveness and higher
occurrences of altered sleep states, resulting in drastic oscillations in sleep that can lead
to a greater chemosensitivity and trigger an increase in ventilation at only slightly
elevated CO2 levels.33
This is further illustrated in a study that examined hypercapnic ventilatory
responsiveness. Fukuoka et al. (2003) sought to understand the effect that peripheral and
central chemoreceptors have on ventilation during graded and steady-state exercise.
Eleven healthy adults each performed two exercise tests under normoxic (21% O2) and
hypoxic conditions (12% O2). To establish a ventilatory threshold for each subject,
participants performed an incremental exercise test until reaching a heart rate of 160 or
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more beats per minute or until they reached 80-90% exhaustion on the Borg fatigue
scale.34 The provocative tests then consisted of constant exercise at 40%, 60%, and 80%
of the ventilatory threshold – conducted under both the normoxic and hypoxic conditions.
Fukuoka et al discovered that hypercapnic ventilatory responsiveness and hypoxic
ventilatory response increased up to 70% of ventilatory dynamics resulting from exercise,
regardless of the increased work rate and under both normoxic and hypoxic conditions.
This study showed a drastic rise in blood CO2 levels from steady-state and graded
cardiovascular exercise occurs regardless of O2 availability that resulted in dynamic
increases in ventilatory drive. Practically speaking, O2 uptake is solely affected by O2
availability and is minimally affected by CO2 production; meaning regardless of O2
availability, CO2 production will continue to trigger chemoreceptors and increase
ventilatory drive as work rate increases. Similar results were found in later studies on
chemoresponsiveness and CO2 sensitivity in athletes under exercise-induced
hypoxemia.8,35–38
Carbon dioxide sensitivity or an individual's tolerance to CO2 has been
challenging to assess as there exists no easily administered or standard field test to
measure the amount of CO2 building up inside the body at any given moment. The effects
of CO2T have been researched for decades.32 Nevertheless, scientists recently started
looking beyond the chemoreceptor response and investigating CO2 sensitivity as a
potentially trainable performance variable. As previously stated CO2T can be viewed
simply as the length of time an individual can hold their breath, or as complexly as “the
ability to endure progressively rising levels of CO2 without resulting in unwanted psychometabolic reactivity”.12
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Psychological Effects of CO2
Correlations between rising circulatory CO2 levels and adverse psychological
effects have been observed. Stoeckel et al. (2017) conducted a study examining the role
CO2 plays in developing and controlling dyspnea.3 Dyspnea can result from a variety of
causes including exercise, stress, anxiety, pulmonary diseases, and even the anticipation
of dyspnea. Sixty-six healthy volunteers underwent 20 blocks of inspiratory resistive load
breathing while undergoing Functional Magnetic Resistance Imaging. Resistive
breathing loads were set to trigger severe or mild dyspnea and were administered in an
alternating fashion. Each instance was either visually or non-visually cued to assess the
difference between the anticipation of dyspnea and unanticipated dyspnea respectively, as
the visual cue would signal the participant that they were about to experience resistive
breathing. The researchers found that with the anticipation of dyspnea, there was a
marked increase in activity in the anterior cingulate cortex.
The anterior cingulate cortex's primary psychological functions are decision
making, emotion, impulse control, and attention allocation while its main physiological
functions are blood pressure and heart rate regulation, particularly during a flight or fight
response. Subjective ratings reported from the State-Trait Anxiety Inventory for intensity
of dyspnea were significantly higher during severe as compared to mild dyspnea (mean ±
SD 0.75 ± 0.63 and 0.64 ± 0.72, respectively, t(65) = 22.80 and t (65) = 16.45, p <
0.001). The Breathless Catastrophizing Scale showed a strong positive correlation with
the anticipatory activation of the anterior cingulate cortex (p = 0.003) and remained
constant when controlling for age (r = 0.05, p < 0.001). This increase in activity was also
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found to be present in participants who directly experienced dyspnea without any
anticipatory visual cues.10
The results of this study point directly to a potential mechanism for assisting
populations that suffer from chronic stress and anxiety. Since the cognitive anticipation
of being out of breath triggers dyspnea and the rise of serum CO2 levels, this anticipation
can create a positive feedback loop and further dyspnea – resulting in higher levels of
stress and anxiety due to the feeling of being out of breath, and so on. Thus, it has been
proposed that possessing a higher tolerance to CO2 and having normal pulmonary
function could interrupt this positive feedback loop, allowing individuals to avoid or
shorten the act of experiencing dyspnea and regain normal ventilation.4 Interrupting the
catastrophizing dyspnea loop with a breathing intervention has potential benefits for
populations other than athletes such as individuals who experience a generalized anxiety
disorder, acute anxiety attacks, or even those who simply experience more than average
stress during any particular moment.4,26,39,40
Manipulation of Tolerance to CO2
Aside from controlling breathing, and improving breathing mechanisms, apnea or
breath-holding protocols have been shown to increase tolerance to CO2. Freedivers have
long used these protocols to increase their tolerance to CO2 and increase their ability to
use O2.10,41 Combining these breath-hold protocols with glossopharyngeal insufflation
(GI) – a breathing technique initially developed for patients experiencing insufficiency
due to poliomyelitis to increase their time being off a ventilator). The glossopharyngeal
insufflation technique works by increasing air that is pumped into the lungs by
contractions of the upper pharyngeal muscles3 which is accomplished by taking rapid
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forceful breaths, "piston breathing", to fill the lungs with a higher volume of air than can
be accomplished by normal ventilation. Using glossopharyngeal insufflation contributes
to competitive breath-hold divers’ ability to stay underwater for a remarkable amount of
time, upwards of 11 minutes. Walterspacher et al. (2011) asked 12 elite competitive
breath-hold divers to complete a battery of lung function tests to establish baseline values
for glossopharyngeal insufflation’s effects on the pulmonary functions. Baseline values
included vital capacity before, during, and after glossopharyngeal insufflation;
esophageal pressure, static lung compliance (being a measurement of the lungs' ability to
expand and stretch), minute ventilation, breathing frequency, and CO2/O2 blood gas
levels. Measurements for static lung compliance were taken at rest, immediately after
glossopharyngeal insufflation, and every minute for five minutes after GI for a total of
three trials. Lastly, the investigators looked at the effect CO2 has on ventilatory drive
(breathing rate). Participants were fitted with an oral mouthpiece, and nasal breathing
was occluded. Mixtures of 6% CO2 and 9% CO2 were administered using the steady-state
method.42
Walterspacher et al. (2011) collected respiratory drive measurements after
participants reached steady-state in minute ventilation and breathing frequency. Of the
12 original participants, four had been previously tested under the same conditions three
years prior and were assessed under the current conditions to observe glossopharyngeal
insufflation and apnea breathing's long-term effects on the pulmonary system. There was
no significant difference between the original and three-year follow-up participants for
static lung compliance at rest, static lung compliance at glossopharyngeal insufflation,
static lung compliance at 1 min post glossopharyngeal insufflation, and static lung
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compliance at 3 min post glossopharyngeal insufflation. There were statistically
significant increases in breathing frequency between 6% CO2 and 9% CO2 compared
with un-occluded free-breathing of normal room air (both p < 0.05). There were also
significant increases in minute ventilation between 6% CO2 and free-breathing, 9% CO2
and free-breathing, and between 6% CO2 and 9% CO2 (all p < 0.001). These results
indicate that long-term glossopharyngeal insufflation in breath-hold diving does not
affect pulmonary function and, more importantly, as it applies to examining CO2 there
was a distinctly blunted response to elevated CO2 levels in breath-hold divers supporting
the investigators' hypothesis that CO2T can be trained and is not simply an inherited
trait.42
Measurement of CO2
As the previous articles have shown, there are many reasons to measure or
monitor a patient or athlete's CO2 production. However, measurement techniques are
limited, and each has its benefits and drawbacks. Arterial blood gas measurement
became the gold standard in measuring levels of blood CO2 in 1924.43 Currently,
samples are gathered using vented plastic syringes where all ambient air is removed from
the sample. Analysis is rapidly performed using an arterial blood gas analyzer with
electrodes that measure PO2, PCO2 and pH. Other values such as bicarbonate and total
CO2 are calculated from the measured values. Ventilation being the flow of air in and out
of the alveoli, and perfusion being the flow of blood to the alveoli. Clinically the
ventilation/perfusion ratio influences the degree to which an individual is experiencing
hypercapnia or an excess of CO2. However, this method is very invasive, painful, costly,
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only gives a moment-to-moment analysis, and requires highly skilled staff to administer
and process the sample.15,31
Because ABG collection relies on a highly trained respiratory therapist or clinical
laboratory technologist to administer the test, as well as being invasive, researchers have
looked at viable alternatives to the standard ABG test to measure CO2 levels. From a
clinical standpoint, blood sampling will consistently give the most accurate and reliable
results if standard testing procedures are followed. A common alternative is VBG, and
previous studies have shown that VBG measurements, when combined with pulse
oximetry, have a high positive correlation to ABG measurements.45,46 In a study
involving 129 participants, Zeserson et. al. collected ABG and VBG samples and
compared PO2, PCO2, pH, bicarbonate, and pulse oximetry between the two blood draws.
Arterial blood was taken from an existing arterial line or the femoral artery, venous blood
was taken from either a venous catheter or a peripheral venipuncture. Researchers found
that there was a strong positive correlation between arterial and venous pH levels (r =
0.94) and PCO2 (r = 0.93). The mean difference between pH levels between venous and
arterial blood gasses was 0.03 (95% confidence interval, 0.03-0.04). The mean
difference between arterial and venous PCO2 was 4.8 mmHg (95% confidence interval,
3.7-6.0 mmHg).45 These results show that VBG can be used in place of ABG for CO2
analysis and would be preferable outside of the control of a hospital setting.44,47,48
Arterialized capillary blood (ACB) sampling is another standardized method used
to analyze blood gas levels. Traditionally ACB is used in infants or elderly individuals
who are not suited for an ABG puncture. 49 Capillary blood collection is a fairly common
practice in and out of clinical settings. Like measuring blood sugar or BL, blood is
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obtained by a skin puncture 1-2.5mm deep using a lancet or automated incision device.
The process is considered to cause minimal pain and discomfort. It is also the least
invasive of the blood collection methods. Blood is “arterialized” when the skin is
warmed just prior to puncture and collection either the fingertip or the earlobe can be
used.50
Many studies have shown that ACB not only has a high correlation to ABG
measurements but is also suitable to be used outside of traditional clinical settings in
more austere environments.51 In a study of 20 healthy adults Lumholdt et al. sought to
validate the collection and analysis of arterialized venous blood as a valid collection
method for blood gas analysis when compared to ABG. Blood samples were processed
using three different methods; the first was held for five minutes and then analyzed, the
second was mixed for five minutes and then analyzed seven minutes after collection, and
the third was held and then processed 15 minutes after collection. No statically
significant differences were found between processing methods. Researchers analyzed
blood samples for PCO2, pH levels, and PO2 and found that though ACB was not a
suitable alternative for PO2, both pH and PCO2 comparisons were statistically significant
(p < 0.05, r = 0.941 and r = 0.924 respectively) and concluded that ACB is a valid
alternative to ABG for pH and PCO2 measurements.52
Capnography, or capnometry, is the collection and analysis of exhaled gases for
CO2 content. After being fitted with a mouthpiece and having the nasopharynx occluded,
exhaled gasses are warmed and dehumidified – exhaled gasses contain 100% humidity
and CO2 must be dried for accurate results.

This method is non-invasive and painless.43

There is also no need for a highly skilled technician to administer the test. Another
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advantage of capnometry is the ability to accurately measure EtCO2. Capnometry;
however, suffers from the need for expensive equipment and handheld versions are less
accurate due to the volume of gasses inhaled vs. exhaled.44
The last of the common CO2 measuring modalities is done via a transcutaneous
sensor. These wearables can either be attached to the arm, chest, or ear. These devices
use a nondispersive infrared sensor, a type of simple spectroscope sensor traditionally
used to measure gases. The basic principle of a transcutaneous CO2 measurement device
works by putting a heated electrode securely and directly onto the skin. This then causes
the natural microcirculation to arterialize. Using the Henderson-Hasselbalch equation,
the production of carbonic acid provides a pH reading which can then be interpreted as
arterial CO2 concentration.53 These devices are non-invasive, convenient, and accurately
measure capillary CO2 blood gas. 14,15,16,44 Ekkernkamp et al. (2015) investigated the
correlation between the most common invasive and non-invasive arterial and capillary
PCO2 measurement methods. 83 patients and 17 healthy adults volunteered for both
invasive and non-invasive PCO2 measuring methods. The invasive method included a
standard blood draw for ABG and an earlobe prick to access capillary blood gas. Noninvasive methods included a transcutaneous sensor placed on the right side of the chest.
Mean differences between ABG and transcutaneous CO2 were 11.9 ± 15.0 mmHg. Mean
difference between right earlobe capillary PCO2 and arterial values was 5.6 ± 7.2 mm Hg,
though acceptable agreements between ABG and capillary PCO2 could not be found.
Researchers concluded that the non-invasive transcutaneous measurement of PCO2 is a
viable alternative to more painful and invasive methods based on a further comparative
analysis, qualitative observations, and the acknowledged limitations of the study.54
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Though these previous results were positive, more research was needed to assess
if this would be a viable method for CO2 monitoring during exercise. In a preliminary
pilot study, Grangeat et al. (2019) tested a new and innovative wearable device for
continuous monitoring of PCO2 called the CAPNO. Researchers used a standard
cardiopulmonary exercise test to evaluate the feasibility and accuracy of a forearm
mounted device for transcutaneous CO2 measurement; as previous methods have been
limited to devices mounted on the chest and ear lobe, both of which are difficult to
implement across a wide range of people and have adherence issues during exercise.
Investigators found a positive correlation (r = 0.74) between the CAPNO and
transcutaneous CO2 measurement at the ear, as well as EtCO2 measured via standard
metabolic cart (p = 0.81). EtCO2 is a typical marker for dead-space ventilation which is
used to evaluate individuals for possible pulmonary emboli. Overall EtCO2 can provide
very useful information regarding CO2 production and offload. The major limitation of
this study is the general nature of case studies. With only one healthy participant
involved, more research needs to be done to evaluate this device fully. However, given
Granger et al. (2019) found a positive correlation to transcutaneous CO2 measured at the
forearm and earlobe, it is plausible to say that along with the results of the previous study,
transcutaneous CO2 measured at the forearm with the CAPNO device would also have a
positive correlation to standard ABG measurements. Another interesting finding is the
strong positive correlation between transcutaneous CO2 and EtCO2.55
EtCO2 measurements collected during 𝑉𝑉̇ O2 max tests are shown to be very valid

and reliable during graded exercise tests. This is another area where a theoretical

correlation could be made between expired CO2 and levels of dissolved CO2. Unlike
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other inert gases, CO2 very quickly and thoroughly diffuses across cell membranes. In a
recent study by Fijimoto et al. (2019) researchers sought to investigate correlations
between EtCO2, arterial, venous, and transcutaneous CO2. Thirty participants underwent
a total of 60 sample trials in which arterial CO2, venous CO2, and transcutaneous CO2
were collected. The resulting values were then compared with continuous monitoring of
EtCO2 via capnometer. Investigators found a strong positive correlation between EtCO2
and ABG measurements (p < 0.001) with a minimal bias of 6.48 mmHg, whereas a weak
positive correlation between ABG and transcutaneous CO2 was found (p = 0.037).
Investigators concluded that ABG agreed with EtCO2 as well as or better than VBG and
transcutaneous CO2 measurements, suggesting that EtCO2 can be used, with minimal loss
of accuracy, in place of ABG measurements.24
The main limitation of using expired gases to evaluate CO2T would be the amount
of CO2 leftover in the blood and the anatomical dead space. End-expiratory lung volume
and anatomical dead space in the lungs are determined by the inhalation and exhalation of
nitrogen gas. Because nitrogen is an inert gas and therefore, does not possess a charge, it
is not quickly diffused into blood from the lungs. The resulting level of expired gas can
be taken from the total inhaled gas to determine the amount of end-expiratory lung
volume and anatomical dead space present in the lungs. CO2 is not used to determine
end-expiratory lung volume because of the ease with which it diffuses out of blood, into
the lungs, and then offloaded through alveolar ventilation. Because CO2 is easily
transported and transferred there is a potentially strong positive correlation between
expired levels of CO2 or the amount of CO2 an individual can offload and the amount of
circulating CO2 an individual can sustain during maximal or sub-maximal effort.56 Tang
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et al. (2012) showed that standard modeling for end-expiratory lung volume and
anatomical dead space relies on the amount of exhaled CO2. Researchers found that this
N2 depletion model can be used to measure end-expiratory lung volume, also resulting in
insignificant amounts of CO2 being left behind. This supports the theoretical validity of a
single timed-breath exhale for the evaluation of CO2T.55–57
CO2 and Physical Activity
As previously explored, dyspnea is a common result of physical exertion; and is
primarily influenced by the rising levels of H+ and secondarily from a rise in CO2. From
a clinical standpoint, it is vital to use the above-mentioned modalities to evaluate levels
of CO2 as a controlled clinical laboratory setting will undoubtedly provide the highest
level of validity and reliability. A standard graded exercise test, or as previously
mentioned, a cardiopulmonary exercise test, can be used to increase levels of CO2
production. Datta et al. (2015) reviewed the most common cardiopulmonary exercise test
protocols and CO2 testing modalities to evaluate exercise-induced dyspnea from a clinical
research perspective. Investigators evaluated results from both field and laboratory tests,
including a six-minute walk, incremental, and endurance walking tests as field options
and a cardiopulmonary exercise test in a laboratory setting. They concluded that though
the field tests were easy to administer, relate to normal activities of daily living, and may
be able to predict morbidity or mortality, they do not give much by way of actual
physiological measurements, whereas the cardiopulmonary exercise test provides a
wealth of physiological data.58 These conclusions highlight the need for reliable
physiological measurements when assessing and treating individuals who suffer from
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exercise-induced dyspnea while also giving rise to difficulties due to the need for
expensive equipment and specialized training.
Validation of Field Tests
Because of the usefulness of field tests to evaluate cardiopulmonary physiological
measurements for athletic testing or clinical application27, it is important to not only
evaluate the validity and reliability of specific field tests with that of gold standard
laboratory tests but also determine the ease with which these tests can be implemented
across various populations. Field tests are an important part of exercise testing as they
not only are easily implemented but also are extremely cost-effective and generally do
not require a high degree of training. A review of 43 studies covering a total of six
commonly used field cardiopulmonary exercise tests included a 20-meter shuttle run (SR20m), 550 m run, a 1-mile run, and timed runs for distance durations of 6, 9, and 12
minutes. Further examination into each field test gave even more correlative data behind
various algorithms used to compute test results. Researchers concluded that the SR-20m
to be the most valid of the six cardiopulmonary exercise tests tested when using the
equation supplied by Barnett et al. (1993). Of the three equations supplied by Barnett et
al. (1993), 𝑉𝑉̇ O2peak = 24.2-5.0 (gender: M = 0; F = 1) – 0.8(age) + 3.4(MS) where MS is
maximal speed calculated by the total number of laps completed during the course of the
test, showed to be the most statically significant results (p< 0.01).59 They also observed
that the 1-mile run could be a suitable alternative to the SR-20m but lacks repeatability
due to the increased testing distance. As subjects were limited to youth athletes, other
equations might need to be used with the same test to evaluate cardiopulmonary
performance in adults or individuals with compromised respiratory systems.
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CO2 accumulation plays a significant role in limiting cardiovascular and
cardiopulmonary exercise and testing12,32,60. An increased blood CO2 level results in
increased ventilatory rate and cardiac output. As previously referenced; elevated CO2
levels, ventilatory rate, and cardiac output cannot be sustained for long periods of time
once the ventilatory threshold is surpassed. This limits maximal exercise and effort must
be decreased to continue physical exertion. Though limited, previous studies have shown
that the ability to have a positive hypercapnic response during activity, i.e. the ability to
withstand higher levels of CO2 without experiencing adverse psychophysiological
responses, is linked to genetics,61 not unlike how 𝑉𝑉̇ O2max is also largely genetic, and

trainable.62 With these factors in mind, the concept of how CO2T can potentially affect

performance outcomes in endurance athletes is applicable and warrants further
investigation into the extent or limits to which this mechanism is trainable.
Studying, training, and improving CO2T is a relativity new area of research.
There have only been a handful of studies that have specifically tried to assess an
individual's CO2T and quantify that measurement. As most CO2 measurement methods
either require a high level of invasiveness or the use of specialized training and
equipment, the limitations are significant when assessing CO2T outside of a clinical
environment. Few studies have used the non-validated CO2T-test of a timed breath
exhale. In a recent study, Murphey, J. & Lafrenz, A. (2020) sought to evaluate the effects
that increasing tolerance to CO2 had on sub-maximal performance in trained cyclists.12
Twenty-four well-trained cyclists were tested for anthropomorphic, maximal
cardiorespiratory, and ventilatory values, and sub-maximal power output before and after
a six-week breathing intervention. Twelve participants served as control and were given
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simple meditative breathing exercises to complete throughout the six-week intervention.
An experimental group consisting of twelve participants was given specific apnea
breathing protocols designed to increase tolerance to CO2.
Participants in both groups were administered the previously mentioned CO2T
field test to assess CO2T, the State-Trait Anxiety Index to measure anxiety levels, and a
Functional Threshold Power (FTP) test in an orally restricted breathing environment to
measure sub-maximal performance under elevated CO2 levels. Because participants
could only breathe through the nasopharynx, less CO2 was offloaded during the test.
Their power output was thus limited by their ability to withstand constantly rising levels
of CO2. The researchers found that breathing protocols increased CO2T and positively
affected sub-maximal threshold power while negatively correlating to state anxiety.
There was a strong positive correlation between pre and post CO2T (r = 0.9) across all
participants in both the experimental and control groups, regardless of breathing
intervention. This high level of internal reliability shows that a timed breath exhale is a
potentially viable field test.12
As previously stated, there is a strong rationale to implement CO2T training in
non-athletic populations. Spirmont P. et al. (2019) and Bentley TGK et al. (2020) both
used the same un-validated timed breath exhale as an assessment of CO2T in their
investigations of CO2 and State-Trait Anxiety.2,4 Spirmont et al. (2019) showed a
negative correlation between performance on the CO2T and state anxiety, while Bentley
et al. showed positive results in implementing slow breathing as an anxiety reduction
method in high school-aged children.2,4
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Conclusion
The information presented in the preceding articles demonstrates the importance
of evaluating CO2T levels in populations including high-level competitive athletes,
individuals suffering from COPD, breath-hold divers, and amateur athletes looking to add
to their training protocols. Though there is still a great need for more research in this
area, enough evidence has been shown to justify the need for a valid and reliable field test
to accurately assess ones' tolerance to CO2. Future studies could look at how more
specific populations are affected by breathwork interventions, examining which breathing
protocols are useful for training and different competition modalities and any potential
benefits from increasing tolerance to CO2 under anaerobic conditions.
These findings could also be particularly useful outside of athletics and clinical
application. Many studies have shown how meditation can lower heart rate and blood
pressure alongside alleviating stress and anxiety. Having the ability to assess CO2T and
then create training protocols to lower CO2 sensitivity could improve the overall quality
of life, especially for those who suffer from chronic stress and anxiety. Future studies in
this area could then examine the psychological effects CO2T has on individuals in their
everyday lives, the psychological aspect of competition, and finally, individuals that work
in high-stress, high-risk situations such as police, military, and firefighters.
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CHAPTER THREE METHODS
Participants
Based on a statistical power analysis (IMB SPSS 2020, College Armonk, NY)
twenty-eight, (n=28, 19 males, 9 females) healthy female and male endurance athletes
between the ages of 18-65 were recruited for this study. Seventeen of which participated
in triathlons (swimming, cycling, and running), eight participated in cycling only, and
three were distance runners only. All participants were currently cardiovascular training
2-4 times per week and strength training 1-3 times per week and were free of any
musculoskeletal, metabolic, and cardiovascular injuries or conditions. Subjects’ training
or racing status in their chosen endurance sport was self-reported on the initial visit. All
potential participants were deemed low risk via the American College of Sports Medicine
(ACSM) screening protocol5,6. The ACSM pre-exercise screening protocol is widely
accepted across various populations as a valid and reliable survey highlighting potential
health risks from strenuous exercise. 63–65 All participants read and signed an informed
consent approved by Boise State University Institutional Review Board (approval #186MED21-007 9/20/2021).
Measurements
Anthropometrics and Medical History
Height (cm) and mass (kg) was measured to the 0.1 cm and 0.01 Kg, respectively
(Charder Height Measurement, Charder Electronic CO, Tanita 300, Tanita Corp.,
Arlington Heights, IL). Body fat (BF%) and lean body mass (LBM) were calculated via
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BodPod (Life Measurement Incorporated, Concord, CA) using the SIRI formula.77
Before each subject testing session, BodPod calibration was performed per the
manufacturer’s recommendation.66 Using air displacement, the BodPod has been
validated against the gold standard in body composition, hydrostatic weighing. The
BodPod is considered a reliable and less expensive alternative with minimal variability (±
3.0 %). 66
Anaerobic Graded Exercise Test:
The 30-second Wingate test was conducted on an electronically braked cycle
ergometer (Velotron bicycle ergometer, Quarq, Chicago, IL) to assess maximum
anaerobic power and increase CO2 production. Resistance loads were calculated and
applied via standard Wingate Ergometer Test specific to each subject (Velotron Wingate
Ergometer Test, Velotron Wingate software). Resistance loads were set at 7.5% of the
study participants’ body mass in kg for females and 8% for males (kg BM). These testing
figures have been shown to produce valid and reliable results as stated by the coaching
and sport science division of United States Cycling. 67,68
Once all anthropometric data were collected for each subject, the Velotron seat
and handlebars were adjusted to each participant’s comfort. Participants completed five
minutes of warm-up interspersed with five 4-6 second sprints at their discretion. Each
subject rested for two minutes after the warm-up before the start of the testing period.
The standard Wingate protocol (30-WT) was used for each testing interval.68 Upon
completing the 30-WT, participants passive rested for two minutes and then completed
another 30-WT, followed by another rest period. The 30-WT tests continued until
participants reached a plateau of 𝑉𝑉𝑉𝑉̇ O2max, volitional fatigue, or at their own

discretion.67,69
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Blood Lactate
BL accumulation was measured at the end of each 30-WT. Samples were
obtained via a finger prick using a sterile lancet and a single drop of blood placed onto a
lactate meter (Lactate +, Nova Biomedical, USA) strip and inserted into the meter. Its
ease of use and relatively cheap cost to operate the Lactate Plus© meter provides
immediate and accurate results.70
Maximal Heart Rate
A Polar® heart rate monitor chest strap (Polar Electro, Finland) was used to
collect peak heart rate. The chest strap was adjusted by the subject themselves for
comfort before testing.
CO2 Measurement
End-Tidal CO2 (EtCO2)
End-tidal CO2 was measured via Capnograph (RespSence, Nonin, Plymouth,
MN). Participants were fitted with a disposable nasal collection cannula (CO2 Sampling
Cannula, Salter Labs, Lake Forest IL) and all anthropomorphic data were entered into the
machine. Sampling began immediately upon testing and continued until the testing
intervals were over.
Maximal Expired CO2 (𝑉𝑉̇ 𝐶𝐶O2 max)

Participants completed the Wingate protocol as previously described on a cycle

ergometer (Velotron bicycle ergometer, Quarq-SRAM, Chicago, IL) while their exhaled
gases were measured. For the duration of the test, participants were fitted with a Hans
Rudolph 7900 series mouth-only mask to capture and measure their exhaled gases and a
padded nose clip to ensure that all exhaled gases went through the mask. Expired gasses
were analyzed via a Parvo Medics TrueOne 2400 metabolic cart (Parvo Medics, Salt
Lake City, UT); leading industry gold standard for clinical testing of cardiovascular
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measurements. The TrueOne has been shown to provide consistent and valid
measurement of all metabolic processes through the use of indirect calorimetry 73,74.
Peak 𝑉𝑉̇ 𝐶𝐶O2 levels were noted at the end of each interval.
CO2T Field Test

Participants performed two trials, each separated by a 5-minute rest. They took
three normal breaths and on the fourth breath, participants inhaled through the nose to
total lung capacity and exhaled slowly and continually through the nose for as long as
possible. Using a stopwatch (Accusplit, PRO SURVIVOR 601x, MA, USA), the
investigator observed and timed the participants' exhale duration. Participants were told
that the trial ends if they either: 1) pause, stop, or otherwise interrupt the continuous
exhale, or 2) inhale. Participants signaled to the researcher with a simple agreed-upon
hand gesture (a "thumbs up") when they began their initial slow exhalation and the
moment the continuous exhale ended.25 Participants were given the opportunity to
practice the procedure prior to actual testing to eliminate results being affected by the
learned testing effect. This method has shown to have a high degree of internal
reliability, but no studies have been conducted on this test's validity. 4,12,26
Procedure
Participants reported to the Human Performance Laboratory (HPL) at Boise State
University on two separate occasions, each day separated by at least 48 hours of rest.
Day 1: Orientation/Informed Consent/anthropometric measurements/CO2T Field Test/
Ventilatory CO2
This visit consisted of study orientation and informed consent, anthropometric
measurements, and baseline maximal anaerobic threshold testing. Anthropometric data
can be found in Table 2. The CO2T field test was used to estimate CO2T. Participants
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then performed 30-WT intervals while all expired gases were collected and analyzed for
peak 𝑉𝑉̇ 𝐶𝐶O2 levels. The test was terminated when a plateau of 𝑉𝑉̇ 𝐶𝐶O2 max and BL levels
were reached, volitional fatigue, or at the subject's discretion. Peak heart rate was also
used as a comparative value and to establish anaerobic threshold. Anaerobic capacity
was defined at a plateau in 𝑉𝑉̇ CO2max followed by a 20% decrease in maximal power

output between intervals. The number of 30-WT intervals was noted for the second day
of testing.
Day 2 – 48 hrs of rest from day 1: CO2T Field Test/EtCO2 /BL Measurements
Participants completed the CO2T field test for internal and intra-rater reliability
upon arrival. After a 5 min rest, participants then completed 30-WT intervals under the
same testing procedures as the previous day of testing. End-tidal CO2 was collected via
EtCO2 testing procedure during the 30-WT intervals, and measurements were recorded at
the end of each interval. Testing was completed when the same number of 30-WT
intervals from the previous day of testing had been reached or at the subject's discretion.
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Data Analysis
Means and standard deviations were calculated for essential anthropometric
characteristics. Physical characteristics, anaerobic capacity, EtCO2, and CO2T changes
across the clinical CO2 tests and CO2T field tests were compared for statistical
significance. Analysis of variance was used to examine differences within groups (sex);
if statistical significance was found, a Tukey post-hoc analysis was used to locate where
the differences were. Differences, within and between tests, were performed using
ANCOVA with baseline variables as covariates to adjust for any differences at pre-test
CO2T between groups. Statistical tests were computed using SPSS 27 (IMB SPSS 2020,
Armonk, NY), and a p-value of < 0.05 was considered statistically significant.
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CHAPTER FOUR: VALIDATION OF NON-INVASIVE CO2 TOLERANCE FIELD
TEST
Introduction
Exercise testing has long been used to measure various functional capacities and
intensity tolerance levels, diagnose cardiopulmonary diseases, identify responses to
disease interventions, and for exercise effectiveness and prescription. There are many
widely accepted clinical laboratory exercise tests, as well as validated field tests.
However, when measuring or calculating physiological variables, such as maximal
oxygen uptake 𝑉𝑉̇ O2max, there exist potential drawbacks when comparing gold standard
laboratory tests to field tests. Field tests inherently do not provide as valid and reliable

values; however, they are much easier to administer, cost-effective, and do not generally
require special equipment or training.
Recent studies have shown that increasing tolerance to CO2 can have sub-maximal
performance benefits in endurance athletes12, and studies have long shown that increasing
tolerance to CO2 is critical for breath-hold divers.21,22 Much like training can affect the
level of lactate build up one can tolerate as seen in lactate threshold training in power and
strength athletes, and training to increase 𝑉𝑉̇ O2max for endurance athletes, training to
increase CO2T has gained popularity in recent years in the freediving community.7,9

Previous research has also shown improving CO2T to be beneficial for lowering blood
acidosis, reducing oxidative stress, and improving state anxiety.3,10–12 However, although
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studies have shown that CO2T can be improved, there is no 'gold standard' test to assess
an individual's actual CO2T.
Outside of clinical laboratory tests, there does not appear to exist a validated
method for measuring CO2T. The previously mentioned studies have used a novel timed
single-breath exhale to evaluate CO2T among their subjects. Using the rationale that the
longer exhalation is limited, CO2 will continue to accumulate in the body until a maximal
tolerable concentration has been reached and normal ventilation must commence.
Though using a timed breath-exhale is a cost-effective and straightforward method
compared with standard clinical tests, it has neither been validated nor implemented in a
controlled setting to be considered truly reliable or valid. The purpose of this study is to
validate the only known current CO2T field test against EtCO2, 𝑉𝑉̇ CO2max, BL production,
and AC in endurance athletes.

Methods
Participants
Thirty-two (n = 32) healthy individuals with no previous experience in breathhold training were recruited. Four participants did not complete the whole study; thus, the
data of 28 participants (n=28, 19 males, 9 females, Table 2.) were used for analysis. All
procedures were approved by the Institutional Review Board (approval #186-MED21007 9/20/2021) and participants provided consent and completed the PAR-Q and ACSM
health questionnaire.5,7

34
Anaerobic Threshold Test
The 30-second Wingate test on an electronically braked cycle ergometer
(Velotron bicycle ergometer, Quarq, Chicago, IL) was used to assess maximum anaerobic
power8. Resistance loads were calculated at:
Females: Test load (kg) = body mass (kg) * 0.075
OR
Males: Test load (kg) = body mass (kg) * 0.083

Table 1

Anaerobic Threshold Test68
Data Collected

20 sec resistance ramp-up @ 2-5% kgBM

Resistance (%
kgBM)
8.3 - males

5 sec cadence ramp-up @ 0% kgBM

7.0- females

HRpeak

Procedure

30 second sprint @ Rx’ed resistance

BL

𝑉𝑉̇ 𝐶𝐶O2 max

2 min passive recovery @ 2% kgBM

EtCO2

Procedures
Data were collected on two separate occasions, each day separated by at least 48
hours of rest. Height (cm) and mass (kg) were measured to the 0.1 cm and 0.01 Kg,
respectively (Charder Height Measurement, Charder Electronic CO, Tanita 300, Tanita
Corp., Arlington Heights, IL). Body fat (BF%) and lean body mass (LBM) were
calculated via BodPod (Life Measurement Incorporated, Concord, CA) using the SIRI77
formula. Participants were also familiarized with the CO2T field test on both days of
testing. See Figure 1. for the study outline.
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Day 1 Testing
The first day of testing consisted of study orientation and informed consent,
anthropometric measurements, and baseline maximal anaerobic threshold testing.
Participants performed repeated 30 sec WT intervals while expired gases were collected
and analyzed. Peak 𝑉𝑉̇ 𝐶𝐶O2, peak heart rate (HRpeak), and power output were monitored

and used as a to establish anaerobic threshold (AT). AT is the point at which a

curvilinear increase in minute ventilation is observed (Owles Point)9, critical power is
reached, and HRpeak or HRmax was observed.10,11 Participants completed Wingate
intervals until HRpeak and plateau of peak power was achieved, volitional fatigue
occurred, or at the discretion of the participant. Each participant passively rested two
minutes between testing intervals. The number of repeated 30 sec WT intervals was
noted for the second day of testing. AC was noted at the end of each 30 sec WT interval
and the highest value was recorded and used to help determine when anaerobic threshold
was met.
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Visit 1

Rest

Informed Consent
and Pre-screening
Questionnaires

Visit 2

Familiarization and
Evaluation of CO2T Field
Test

Body
48 Hours
Familiarization and
Evaluation of CO2T
Field Test

Wingate Intervals
EtCO2

Wingate Intervals
VCO2max, HRpeak , AC

Blood Lactate

CO2: Carbon Dioxide, CO2T: Carbon Dioxide Tolerance, VCO2max: Maximal
Exhaled Carbon Dioxide, AC: Anaerobic Capacity, EtCO2 End-Tidal Carbon Dioxide,
HRpeak : Peak Heart Rate
Figure 1

Study Outline of Visits and Variables Measured

Day 2 Testing
On day 2, participants completed a second CO2T field test for internal and intrarater reliability. After a 5 min rest, participants then repeated the 30 sec WT intervals
using the same testing protocol. EtCO2 values were collected via capnometer and at the
end of each interval, BL was measured via blood obtained from a finger prick. Testing
was terminated when the same number of 30-sec WT intervals from the previous day was
reached or at the subject's discretion.
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Data Analysis
Mean and standard deviations were calculated for anthropometric characteristics.
Physical characteristics, anaerobic capacity, EtCO2, and CO2T changes across the clinical
CO2 tests and CO2T field tests were compared for statistical significance (SPSS 27 (IMB
SPSS 2020, Armonk, NY). Analysis of variance was used to examine differences within
groups (sex); a Tukey post-hoc analysis was used to identify where the ANOVA
differences were. Differences, within and between tests were determined using
ANCOVA with baseline variables as covariates to adjust for any differences at pre-test
CO2T between groups. Data are presented in means ± SD with an alpha level ≤ 0.05.
Results
All subject and group demographics can be found in Table 2. Mean ± SD for all
primary and secondary research variables can be found in Table 3. All subjects who
completed both days of testing met end-range criteria for established maximal CO2
production.
Table 2

Study Participant Characteristic
Male

Female

Mean±SD

Mean±SD

Height (cm)

180.85 ± 6.25

165.98 ± 2.17

Mass (Kg)

77.47 ± 7.69

61.43 ± 6.28

Age (years)

37.05 ± 9.60

37.89 ± 10.28

BF (Kg)

16.33 ± 7.79

22.00 ± 6.25

LBM (Kg)

79.57 ± 18.53

78.02 ± 6.22
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Table 3

Mean ± SD for all Research Variables Between Sex

Group (sex) Statistics
Sex

Mean±SD

Std. DV

Male

7.96 ± 1.25

0.29

Female

7.26 ± 1.19

0.40

EtCO2rel
(mmHg)

Male

0.31 ± 0.14

0.03

Female

0.24 ± 0.09

0.03

EtCO2abs
(mmHg)

Male

8.47 ± 5.15

1.18

Female

6.44 ± 3.13

1.04

𝑉𝑉̇ 𝐶𝐶O2max
(ml/kg/min)

Male

51.59 ± 6.75

1.55

Female

47.68 ± 7.58

2.53

BLrel (mmol)

Male

0.55 ± 0.30

0.07

Female

0.57 ± 0.33

0.11

Male

5.18 ± 1.61

0.37

Female

5.22 ± 2.27

0.76

Male

179.58 ± 8.01

1.84

Female

176.22 ± 10.63

3.54

Male

43.81 ± 27.49

6.31

Female

40.00 ± 12.06

4.02

AC (W/kg)

BLabs (mmol)

HRpeak (BPM)

CO2Tavg (Sec)
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CO2 Tolerance
Participants completed two CO2T trials and an average was taken each day. Day
1 and Day 2 CO2T times were not found to be statically different (p = 0.181) and showed
a high positive correlation to each other. (r = 0.989, p < 0.001). Therefore, an average of
the scores was used for comparisons to primary and secondary research variables. There
was a direct correlation to HRpeak (r = 0.380, p < 0.05) and an inverse relationship to
EtCO2(1) (r = -0.393, p < 0.05). Differences in means between sexes was shown to be
significant (t(26) = 0.395, p < 0.05, figure 2). No significant correlations were found
between average CO2T and all primary research variables (BLabs, BLrel, EtCO2abs, and
EtCO2rel, and 𝑉𝑉̇ 𝐶𝐶O2max).

Figure 2

CO2T Distribution by Sex
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Primary Research Variables
End-Tidal CO2 values for all participants decreased from intervals 1-4 whereas
BL values increased (see Figs. 2 and 3). A one-way ANOVA showed that EtCO2 and BL
values between intervals were significantly different (p < 0.001) within groups (sex), but
not between groups (p = 0.729 and p = 0.703 respectively). Because of the wide variety
in individual absolute values, relative values were calculated for EtCO2 and BL and used
for comparisons. All four EtCO2 values were also cross correlated to CO2Tavg times.
EtCO2(1) showed a moderate negative correlation to CO2T (r = -0.393, p < 0.05). No
other significant correlations or differences were observed between CO2T and any other
primary or secondary research variable including AC (r = 0.005, p < 0.491). Table 4
shows all correlations between CO2T and all primary research variables.
There were no significant differences between 𝑉𝑉̇ 𝐶𝐶O2max values between sexes (p

< 0.181). Peak exhaled CO2 showed a moderate positive correlation to LBM (r = 0.513, p
< 0.01), VE (r = 0.429, p < 0.05), 𝑉𝑉̇ CO2 (r = 0.403, p < 0.01), and height (r = 0.368, p <

0.05); and an inverse relationship to BF (r = -0.538, p < 0.01). There was no correlation
to CO2T; however, the level of significance was not met (r = 0.005, p = 0.491) There
were no significant differences between 𝑉𝑉̇ 𝐶𝐶O2max values between sex (p < 0.181).
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Figure 3 and Figure 4
Table 4

Changes in BL and EtCO2 across intervals

Correlations between CO2Tavg and all Research Variables

Discussion
The purpose of this study was to validate the only currently known CO2T field
test against measured CO2, maximal ventilatory CO2, and anaerobic capacity in
endurance athletes. We hypothesized that the CO2T field test would have a strong
positive correlation to clinical CO2 measurements, there would be no observed
differences between groups among any measured variable, and anaerobic capacity would
have a negative correlation to CO2T. Based on the results here, we reject all three of the
hypotheses.
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This study did not find any meaningful relationship to the duration of a singlebreath exhale and clinical CO2 measurements. There was a strong positive correlation
between the two CO2T tests and this is consistent with previous studies which used the
timed single-breath exhale test to measure individuals’ CO2T.2–4 These results show that
the single-breath exhale has a high degree of intrarater reliability but does not speak to
the validity of the measurements. Previous studies have validated the CO2T test as a
measure of state and trait anxiety however these results only correlated exhale times to
survey scores from the State-Trait Anxiety Index and did not use any clinical CO2
measurements giving little insight into what the novel CO2T test is actually measuring.
One possibility as to why none of the CO2T values showed any correlations to
clinical CO2 measurements could be within the test itself. Though each individual
participant was coached on how to complete the test and was given as many practice
times as needed, the test relies heavily on mental restriction of exhalation as opposed to
mechanical restriction. Investigators observed an increase in time over the practice
sessions for all participants. Once exhalation times started to plateau the coaching was
stopped and participants completed one more test and values were recorded.
Comparisons of EtCO2 measurements and CO2T times showed no statically significant
results. All participants showed a decrease in EtCO2 across the testing intervals, which is
to be expected as for output to continue, ventilation would have to increase and EtCO2
would subsequently decrease. If the CO2T test was a valid measure of CO2, then
regardless of the overall decrease in EtCO2, participants with overall higher EtCO2 values
should have been able to exhale for a longer duration of time which was not measured or
observed and can been seen in Fig 5. It is more likely that the CO2T test is measuring
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one’s ability to simply control exhalation and resist re-breathing from a psychological
standpoint rather than actual levels of CO2.
Previous studies have shown that strenuous aerobic training can lead to an
increase in pulmonary function measures such as vital capacity, maximal voluntary
ventilation, and total lung capacity, regardless of age.75 As age was not shown to be a
factor in CO2T test outcomes or EtCO2 values and there was no control for the level at
which the participants were at in their respective sport, it is plausible that the participants
who were highly trained had the ability to ventilate more efficiently during maximal
efforts. Though the testing modality was not aerobic by nature many mid to high level
endurance athletes purposely train strenuous anaerobic intervals as anaerobic training can
lead to increases in aerobic capacity.76 Thus, when tasked with repeated anaerobic
threshold intervals the participants who were highly trained were able to control the
single-breath exhale for an extended period of time and were more efficient at offloading
CO2.
Some limitations should be considered in the present study. As previously stated
not controlling for participant training or ability can be seen as a limitation and could
have affected the outcome of the results. Our results for CO2T could not be compared to
gold standard CO2 measurements for actual ABG or VBG. Even though EtCO2 can be
used as a comparative value79, actual blood gas measurements may have shown a more
accurate correlation. Under normal circumstances, EtCO2 measurements are slightly
lower than partial pressure arterial CO2 and will decrease with exercise, which was
observed across all participants. Though these observations align with previous research,
there were no significant correlations between any EtCO2 values and CO2T test times.
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Regardless of the decrease in EtCO2 times over the testing intervals and because EtCO2
values accurately correlate to arterial levels of CO2; if the CO2T test was accurately
predicting CO2 levels, then participants with higher CO2T times should also have higher
overall EtCO2 values showing their ability to function under higher levels of CO2; the
opposite of this was observed. This could be due to the collection method, as EtCO2 was
measured via nasal cannula, and as previously participants with higher CO2T times may
be better at controlling pulmonary function and are simply better at ventilating during
maximal efforts, resulting in lower EtCO2 values. As previous research correlating
EtCO2 and arterial CO2 pressure has primarily been done on subjects with cardiopulmonary dysfunction, it is possible that EtCO2 values were not accurate due to
increased ventilation from higher output in normal functioning individuals during
exercise.
The results from the present study can only be generalized to endurance athletes
between the ages of 18 and 65. This athletic population can be considered a delimitation
and future research should include non-athletic populations including those with and
without a cardio-pulmonary afflictions. There has been substantial previous research on
the effects CO2 has on individuals with COPD, however these studies are highly clinical
by nature.80-82 As all the participants in the present study were able to effectively off-load
CO2 during exercise and may have altered their CO2T, the possibility exists that the novel
CO2T test may have a higher correlation to clinical CO2 values in the untrained or those
who already possess a high degree of CO2 sensitivity. Each of these populations have
been shown to have diminished pulmonary functions when compared to athletes;
correlations between the CO2T test and clinical measurements among these populations
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would also support the conclusion that the novel CO2T is a better measure of pulmonary
function in athletes as opposed to actual CO2 levels.30,83,84
Other future research should consider comparing the CO2T field test results to
maximal breath holds and maximal breath holds to these same clinical measures of CO2
production. As previously explained, CO2 will continue to build regardless of O2
availability, and ventilatory response must increase if output is maintained or increased.85
Because of this, there is a possibility of a maximal breath-hold having a higher degree of
correlation to actual CO2 levels.78 Because the CO2T test seems to function more as a
measure of pulmonary control rather than actually measuring circulating levels of CO2
future studies should focus on comparing outcomes from the CO2T test to pulmonary
function tests to determine if the field test provides a better correlation. As highlighted
from previous literature the “crossover point” or ventilatory threshold might be a better
indicator of CO2T; future studies attempting to correlate the CO2T field test to clinical
cardiopulmonary measurements should include ventilatory threshold as a primary
research variable. Lastly, future studies attempting to implement or validate the novel
CO2T test should test participants during or after exercise. Because exhalation at rest in
healthy individuals offloads all unnecessary CO2 it is plausible that CO2T values after
anaerobic intervals, or during aerobic exercise could be more representative of CO2 levels
when breathing is compromised from increased physical exertion.
In summary, though the application of a timed single-breath exhale has a high
degree of reliability, there is no evidence to support the notion that this novel field test
accurately represents levels of produced CO2. Furthermore, as ventilation during
exercise in healthy adults provides ample CO2 offloading, there does not seem to be a
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need to evaluate CO2 for the purposes of aerobic training under normal respiration
conditions. As previous findings have shown it is possible to train CO2 tolerance through
the practice of apnea breathing protocols within the freediving community, more research
needs to be done to support the timed single breath field test as a valid measure of
tolerance to CO2 and/or to find a more valid field test.
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Physical Characteristics
Participant age was inversely correlated to HRpeak (r = -0.431, p < 0.05), LBM (r
= -0.426, p < 0.05); and was directly correlated to BF (r = 0.363, p < 0.05). Lean body
mass showed a positive correlation to 𝑉𝑉̇ 𝐶𝐶O2max (r = 0.513, p < 0.01) and height (r =

0.444, p < 0.01). Subject demographics can be found in Table 2. Group statistics for all
primary and secondary research variables can be found in Table 3.
Clinical CO2 Measurements
Maximal Exhaled CO2
Maximal exhaled CO2 values were recorded five seconds post 30-WT to allow for delay
in exhalation and instrument capture. There were no significant differences between
𝑉𝑉̇ 𝐶𝐶O2 max values between participants or groups (p < 0.01, p < 0.05 respectively). There

was a small positive correlation to CO2T but did not reach statistical significance (r =
0.115, p = 0.280).
End-Tidal CO2

A paired t-test reviled EtCO2 values between tests were significantly different (1.10 ± 2.54, t(27) = -1.37, p < 0.001). Absolute and relative change values were
calculated across all four EtCO2 tests and Mean±SD are reported in Table 2. Neither
relative nor absolute EtCO2 showed a significant correlation to CO2T. All four EtCO2
values were cross correlated to CO2T times and EtCO2(1) showed a moderate negative
correlation to CO2T (r = -0.393, p < 0.05). There were no observed differences between
groups for any EtCO2 measurement. All participants experienced a decrease in EtCO2
across intervals 1-4 as seen in Fig 3. Figure 4 represents the relationship between CO2T
times and EtCO2 beginning and ending values.
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Figure 5

CO2T and EtCO2 Comparison

Secondary Variables
Peak Heart Rate
Peak heart rate was recorded at the end of each testing session. No significant
differences were found between testing days (p = 0.435). The average between testing
days was used for comparisons. A moderately positive correlation was found between
HRpeak and CO2T (r = 0.380, p < 0.01) and 𝑉𝑉̇ CO2max (r = 0.335, p < 0.05) and a

moderate negative correlation between age (r = -0.431, p < 0.05) and BF (r = -0.341, p <
0.05) was also observed. There were no statically significant differences between groups
for HRpeak. Mean ± SD are reported for participants and groups in Table 3.
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Anaerobic Capacity
Aerobic Capacity was noted after each interval and the highest value was
recorded. Anaerobic capacity showed no correlation to any of the primary or secondary
testing variables at or beyond significance level. A test of between group effects showed
no significant differences (t(26) = 1.41, p = 0.171).
Lactic Acid
A paired t-test reviled BL values between tests were significantly different (-4.89
± 2.54, t(27) = -10.16, p < 0.001). Absolute and relative change values were calculated
across all four BL tests and Mean±SD are reported in Table 3. No correlations between
BL and CO2T, or any other research variable reached statistical significance. Absolute
and relative BL measurements showed no significant differences between groups. Lactic
acid increased across all participants from intervals 1-4 as seen in Fig 2.
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As previously stated EtCO2 fell across all intervals among all participants and BL
rose in a similar fashion, which can be seen in Figures 2 and 3, which is to be expected as
participants tried to maintain anaerobic output throughout the duration of the graded
exercise test. Likewise, AC was used to determine when the participants had reached a
plateau and AC values consistently decreased over time. It was hypothesized that AC
would have a negative correlation to CO2T times, meaning the longer the duration of
exhalation the lower AC would be. The rationale behind this lies in differences between
pure endurance athletes and though that have a greater ability to produce anaerobic
power. Previous studies have shown there to be no correlation between anaerobic efforts
and CO2T14,15 where as others have shown a positive relationship among endurance
athletes2.
Though these studies used CO2T as a measurement value moreover the focus was
on nasal vs. oral breathing. Since the participants were breathing primarily through their
nose during the EtCO2 collection phase, the distribution of participants who had higher
AC should have had lower overall CO2T scores, lower EtCO2, and higher BL, which was
either observed or measured. Again, one possible reason for this could be the previously
described nature of the CO2T test, or simply that the CO2T test does not measure an
individual’s level of CO2 but their ability to control breathing rates, especially when nasal
breathing.
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Date:

September 20, 2021

To: Shawn Simonson
cc:Joshua Murphey
From: Biomedical Institutional Review Board
(MED-IRB) c/o Office of Research
Compliance (ORC)
Subject: MED-IRB Notification of Approval - Original – 186-MED21-007
Validation of Non-Invasive CO2 Tolerance Field Test
The Boise State University IRB has approved your protocol submission. Your
protocol is in compliance with this institution’s Federal Wide Assurance (#0000097) and
the DHHS Regulations for the Protection of Human Subjects (45 CFR 46).
Protocol
186Received:
Number: MED21-007
Approved:
Expires:
9/19/2022

7/26/2021 Review:
9/20/2021Category:

Expedited
2, 4

Your approved protocol is effective until 9/19/2022. To remain open, your protocol must
be renewed on an annual basis and cannot be renewed beyond 9/19/2024. For the activities to
continue beyond 9/19/2024, a new protocol application must be submitted.
ORC will notify you of the protocol's upcoming expiration roughly 30 days prior to
9/19/2022. You, as the PI, have the primary responsibility to ensure any forms are submitted in a
timely manner for the approved activities to continue. If the protocol is not renewed before
9/19/2022, the protocol will be closed. If you wish to continue the activities after the protocol is
closed, you must submit a new protocol application for MED-IRB review and approval.
You must notify the MED-IRB of any changes to your approved protocol and the
committee must review and approve these changes prior to their commencement. You should
also notify the committee if your activities are complete or discontinued.
Current forms are available on the ORC website at http://goo.gl/D2FYTV
Please direct any questions or concerns to ORC at 426-5401 or
humansubjects@boisestate.edu. Thank you and good luck with your research.
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INFORMED CONSENT FORM
Study Title: Validation of a Non-Invasive CO2 Tolerance
Field Test
Principal Investigator: Josh Murphey
Co-Principal Investigator: Dr. Shawn Simonson
Sponsor: Boise State University

You are invited to participate in a research study. This consent form will provide
you the information you will need to understand why this study is being done and why
you are being invited to participate. It will also describe what will be expected of you as
a participant, as well as any known risks, inconveniences or discomforts that you may
have while participating. We encourage you to ask questions at any time. If you decide
to participate, you will be asked to sign this form and it will be a record of your
agreement to participate. You will be given a copy of this form to keep.
PURPOSE AND BACKGROUND
The purpose of this study is to validate the only known current CO2 tolerance field test
against measured maximal dissolved CO2 and maximal ventilatory carbon dioxide in
endurance athletes. We expect approximately 22 volunteers. No one will be paid to be in
the study. We will begin enrollment on 08/01/2021 and end enrollment on 12/01/2021.
PROCEDURES
If you agree to be in this study, you will participate in the following:
We will set up a time for you to meet one of the Boise State University Human
Performance Lab investigators on two separate occasions, each day separated by at least
48 hours of rest. Day one will consist of anthropomorphic measurements, a timed breath
exhale, venous blood gas measurement, and measurement of maximal ventilatory CO2
during a maximal anaerobic threshold testing. Day two will consist of blood lactate
measurement and measurement of end-tidal CO2 during maximal anaerobic threshold
testing. Day three will consist of a threshold CO2 Tolerance test. Data collection will be
led by the Primary Investigator, Joshua Murphey, Co-Investigator, Professor Dr. Shawn
Simonson at Boise State University will also assist in data collection.
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RISKS
Maximal effort exercise testing can cause feelings of light-headedness, dizziness,
nausea, exhaustion, and possible muscle soreness. A proper warm-up and cool-down will
help diminish the risk of these side effects. Anaerobic threshold testing used in this study
is a common practice in the lab and the field of exercise science in general.
Risks of timed exhale and breath-hold Tests: The breath-hold tests and timed
exhale tests can cause temporary light-headedness and minor discomfort. Due to the
nature of the testing, participants will likely experience feelings of breathlessness and the
associated discomforts during the tests. In very rare cases, prolonged breath-holding may
lead to faintness or momentary loss of consciousness. However, participants will be
explicitly instructed to cease the breath-hold if they encounter faintness. In addition,
participants may terminate the test at any time. Also, due to the nature of the test (to
measure participants' physical and mental capacities for breath-hold-associated
sensations), participants will cease testing at the limits of their capacities and not beyond.
The researcher will be monitoring the duration of the test to ensure the safety of the
participant
Occasionally one or more of the following potential side effects of taking blood
samples may occur: pain, bruising, slight bleeding, light-headedness, fainting, and
(rarely) an infection. A trained technician will be drawing the blood. The treatment or
procedure may involve risks that are currently unforeseeable. There are no known risks or
discomforts from the saliva collection technique.
There are no other risks aside from collecting your information.
BENEFITS
You will not derive any direct benefit, and with the information you provide, the
protentional to society would be the validation of a CO2 Tolerance Field test which could
have further beneficial research and training applications.
EXTENT OF CONFIDENTIALITY
Reasonable efforts will be made to keep the personal information in our research records
private and confidential. Any identifiable information obtained in connection with this
study will remain confidential and will be disclosed only with your permission or as
required by law. The members of the research team and the Boise State University Office
of Research Compliance (ORC) may access the data. The ORC monitors research studies
to protect the rights and welfare of research participants.
Your name will not be used in any written reports or publications which result from this
research.
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Data will be kept for at least 3 years (per federal regulations) after the study is complete
and then destroyed.
PAYMENT/COMPENSATION
You will not be paid or compensated for your participation in this research study.
PARTICIPATION IS VOLUNTARY
Your decision to participate in this research study is entirely voluntary. Your
participation is greatly appreciated, but we acknowledge that the tasks being performed
may have the potential to cause physical or emotional duress. You are free at any point
to choose not to engage with or stop the study. You may choose not to participate in any
portion of the preliminary testing, study intervention, or post-testing. This study is not
required, and there is no penalty for not participating. If at any time you experience a
negative emotion or physical effect from any portion of the preliminary testing, study
intervention, or post-testing, we will stop any test being performed, or you may choose to
withdraw yourself\
QUESTIONS
If you have any questions or concerns about your participation in this study, you may
contact the Principal Investigator, Dr. Missy Elliott: 208-426-0000 or or Dr. Shawn
Simonson:
This study has been reviewed and approved by the Boise State University IRB (IRB). If
you have questions about your rights as a research participant, you may contact the IRB,
which is concerned with the protection of volunteers in research projects. You may reach
the board through the Office of Research Compliance by calling (208) 426-5401 or
emailing humansubjects@boisestate.edu.
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DOCUMENTATION OF CONSENT
I have read this form and the descriptions of this research study. I have been
informed of the risks and benefits involved and all of my questions have been answered
to my satisfaction. Furthermore, I have been assured that any future questions I may
have will also be answered by a member of the research team. I understand I can
withdraw at any time. I voluntarily agree to take part in this research study.

Printed Name of Study
Participant

Signature of Study
Participant

Signature of Person Obtaining Consent

Date

Date
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ACSM HEALTH STATUS & HEALTH HISTORY QUESTIONNAIRE
This form includes several questions regarding your physical health – please
answer every question as accurately as possible. Please ask us if you have any questions.
Your responses will be treated in a confidential manner.
PERSONAL INFORMATION
Last Name:

First Name:

Gender: F M
Mobile:

___

Date of Birth

YES

NO

/

/

Height

Email:
Weight

(ACSM HEALTH SCREEN)

□ □ Do you have any personal history of heart disease (coronary or atherosclerotic
□

disease)?

□ Any personal history of diabetes or other metabolic disease (thyroid, renal,

liver)?

□ □ Any personal history of pulmonary disease, asthma, interstitial lung disease or
cystic fibrosis?

□ □ Have you experienced pain or discomfort in your chest apparently due to blood
flow deficiency?

□ □ Any unaccustomed shortness of breath (perhaps during light exercise)?
□ □ Have you had any problems with dizziness or fainting?

□ □ Do you have difficulty breathing while standing or sudden breathing problems
at night?

□ □ Have you experienced a rapid throbbing or fluttering of the heart?
□ □ Do you suffer from ankle edema (swelling of the ankles)?
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□ □ Have you experienced severe pain in leg muscles during walking?
□ □ Do you have a known heart murmur?

□ □ Has your serum cholesterol been measured at greater than 200 mg/dl?
□ □ Are you a cigarette smoker?
□
□
□
□
□

□ Has your HDL (the "good" cholesterol) been measured at greater than 60
mg/dl?

□

Would you characterize your lifestyle as "sedentary"?

□ Have you had a high fasting blood glucose level on 2 or more occasions
(>=110mg/dl)?

□ □ Are you 20% or more overweight or have you been told your “BMI” was greater
than 30?

□ Have you been assessed as hypertensive on at least 2 occasions (systolic >
140mmHg or diastolic > 90mmHg)?

□ Do you have any family history of cardiac or pulmonary disease prior to age 55?
MEDICAL HISTORY
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□ Are you currently being treated for high blood pressure?
If you know your average blood pressure, please enter:

/

Please check all conditions or diagnoses that apply:

□ Stroke?
□ Limited Range of Motion?□ Do You Suffer from
□ Arthritis?
□

□Abnormal EKG?
□Abnormal Chest X-Ray?
□ Rheumatic Fever?
□ Low Blood Pressure?
□ Asthma?
□ Bronchitis?
□ Emphysema?
□ Other Lung
Problems?

Bursitis?

□

Swollen or Painful Joints?

□

Epilepsy or Seizures?

□

Chronic Headaches or Migraines?

□

Persistent Fatigue?

□

Stomach Problems?

Foot Problems?

□

Knee Problems?

□

□
□

Back Problems?

□

Hernia?
Anemia?

□

Are You Pregnant?

Shoulder Problems?

□ Recently Broken Bones?
□ Has a doctor imposed any activity restrictions? If so, please describe:
________________________________________________________________________
___________________
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FAMILY HISTORY
Have your mother, father, or siblings suffered from (please select all that apply):

□ Heart attack or surgery prior to age 55.

□ High cholesterol

□ Stroke prior to age 50.

□ Diabetes

□ Congenital heart disease or left ventricular

□ Obesity hypertrophy.

□ Hypertension

□ Asthma

□ Leukemia or cancer prior to age 60.

□ Osteoporosis

MEDICATIONS
Please Select Any Medications You Are Currently Using:

□ Diuretics
□ Beta Blockers

□ Other Cardiovascular
□ NSAIDS/Anti-inflammatories (Motrin,
Advil)

□ Vasodilators

□ Cholesterol

□ Alpha Blockers

□ Diabetes/Insulin

□ Calcium Channel Blockers

□ Other Drugs (record below).

LIFESTYLE

□ Are you a cigarette smoker?

If so, how many per day?
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□ Previously a cigarette smoker?

If so, when did you quit?

How many years have you smoked or did you smoke before quitting?
Do you/did you smoke (Circle one): Cigarettes

Cigars

Pipe

Please Rate Your Daily Stress Levels (select one):

□ Low □ Moderate □ High but I enjoy the challenge □ High: sometimes
□ High: often difficult to handle

difficult to handle

1 pub measure of spirits (Gin, Vodka
etc.)

1

□ Do you drink alcoholic

1 can of beer

1.5

1 bottle of strong lager

2.5

beverages?

1 can of strong lager

4

How many units of alcohol do
you
consume per week:
(see Alcohol Units Chart)

1 bottle of wine

7

1 liter bottle of wine

10

1 bottle of fortified wine (port, sherry
etc.)

14

1 bottle of spirits

Alcohol Units Table
Type of Drink

Units

½ pint of beer

1

1 glass of wine

1

30
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Dietary Habits. Please Select All That Apply.

□

I seldom consume red or high-fat meats.

□

I eat at least 5 servings of

fruits/vegetables per day.

□
□

I pursue a low-fat diet.

□

I almost always eat a full, healthy breakfast.

My diet includes many high-fiber foods.

□

I rarely eat high-sugar or high-fat

desserts.

OTHER HEALTH HISTORY INFORMATION
Please indicate any other medical conditions or activity restrictions that you may have, or
any other information you feel is critical to understanding your readiness for exercise. It
is important that this information be as accurate and complete as possible.

HEALTH AND FITNESS GOALS
Please indicate your personal health and fitness-related goals (select all that apply):
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□ Cardiovascular Fitness

□ Injury Rehab

□ Muscular

□ Look Better

□ Reduce

□ Lose Weight

□ Reduce

Strength

□ Feel Better
Stress

□ General Fitness
Back Pain

□ Improve Diet

□ Lower Cholesterol/Blood Pressure □ Sport-Specific

Training

□ Improve Flexibility

□ Muscular Size

Smoking
Please tell us a little about your exercise patterns and goals:
What is your exercise history?
What health improvements do you need?

What are your activity preferences?

What barriers to success do you anticipate?

How will you know that you are succeeding?

□ Stop
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What is your motivation level?

What is your confidence

level?
□ High
Medium

□ Medium

□ Low

□ High

□

□ Low

I verify that all of the completed information is correct to the best of my knowledge. I
declare that I am participating voluntarily in a performance fitness test. The maximum
exertion during the test is at my discretion and I understand that I can stop the test at any
time. I declare that I have no medical problems that prevent me from undertaking the
fitness test and that I am not currently taking any medication that could present a danger
with the performance fitness test.
______________________________
_______________________________
Signature

Emergency Contact:
____________________________

_______________ Printed Name

Date

Mobile:
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DEBRIEFING FORM
Study Title: Validation of Non-Invasive CO2 Tolerance Field Test
Principal Investigator: Dr. Shawn Simonson

Co-Investigator: Joshua Murphey

Thank you for participating in this study. This form describes the background and
purpose of this investigation in more detail. This is an ongoing project and all
participants who fit the inclusion criteria are welcome. Please feel free to share
your experiences during the study and have anyone interested in participating
contact the principal investigator.
The purpose of this study is to validate the only known current carbon dioxide (CO2)
tolerance field test against measured maximal dissolved CO2 and maximal ventilatory
CO2 in endurance athletes. Validation of this field test will allow for more accurate
assessment of CO2 tolerance outside of a lab and give more individuals the ability to
implement CO2 tolerance as a part of their training. For more information about this
topic, please see . Shift Adapt is solely a resource for CO2 tolerance training and is not
in any way affiliated with this project.
If you have any additional questions about the study or if you would like to receive a
copy of the manuscript from this study when it becomes available, please contact Joshua
Murphey at JoshMurphey@u.boisestate.edu or 216-906-2428
If you have questions about your rights as a research participant or concerns or
complaints about the research, you may contact the Boise State University Institutional
Review Board (IRB), which is concerned with the protection of volunteers in research
projects. You may reach the board office between 8:00 AM and 5:00 PM, Monday
through Friday, by calling (208) 426-5401 or by writing: Institutional Review Board,
Office of Research Compliance, Boise State University, 1910 University Dr., Boise, ID
83725-1138.
We appreciate that you took the time to participate in this study.
Thanks again for your participation!
Josh Murphey
Graduate Teaching Assistant

